• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Sapiens Reports Fourth Quarter 2024 Financial Results

    2/18/25 5:51:00 AM ET
    $SPNS
    Computer Software: Prepackaged Software
    Technology
    Get the next $SPNS alert in real time by email

    ROCHELLE PARK, N.J., Feb. 18, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the fourth quarter ended December 31, 2024.

     

    Sapiens Logo

     

    Summary Results for Fourth Quarter 2024 (USD in millions, except per share data)



    GAAP



    Non-GAAP





    Q4 2024

    Q4 2023

    % Change

    Q4 2024

    Q4 2023

    % Change

    Revenue

    $134.3

    $130.9

    2.6 %

    $134.3

    $130.9

    2.6 %

    Gross Profit

    $60.1

    $55.9

    7.5 %

    $62.7

    $59.4

    5.6 %

    Gross Margin

    44.8 %

    42.8 %

     200 bps

    46.7 %

    45.4 %

    130 bps

    Operating Income

    $21.7

    $20.1

    8.0 %

    $24.5

    $24.2

    1.3 %

    Operating Margin

    16.2 %

    15.4 %

     80 bps

    18.2 %

    18.4 %

    -20 bps

    Net Income (*)

    $17.9

    $17.0

    5.3 %

    $20.7

    $20.1

    3.1 %

    Diluted EPS

    $0.32

    $0.30

    6.7 %

    $0.37

    $0.36

    2.8 %

     

    Summary Results for Full Year end 2024 (USD in millions, except per share data)



    GAAP

    % Change

    Non-GAAP

    % Change



    2024

    2023



    2024

    2023



    Revenue

    $542.4

    $514.6

    5.4 %

    $542.4

    $514.8

    5.4 %

    Gross Profit

    $238.1

    $219.6

    8.4 %

    $248.9

    $233.0

    6.8 %

    Gross Margin

    43.9 %

    42.7 %

    120 bps

    45.9 %

    45.3 %

    60 bps

    Operating Income

    $85.8

    $78.9

    8.9 %

    $98.7

    $94.1

    4.8 %

    Operating Margin

    15.8 %

    15.3 %

    50 bps

    18.2 %

    18.3 %

    -10 bps

    Net income (*)

    $72.2

    $62.4

    15.6 %

    $83.3

    $75.0

    11.0 %

    Diluted EPS

    $1.29

    $1.12

    15.2 %

    $1.48

    $1.35

    9.6 %

    (*) Attributable to Sapiens' shareholders

    Roni Al-Dor, President and CEO of Sapiens, stated, "In the fourth quarter we achieved $134 million in revenue, a 2.6% year over year increase. This quarter showcased solid execution across our key regions and ongoing growth of our core Life business. For the full year 2024, we delivered a 5.4% increase in revenue, reflecting the signing of deals with new and existing customers. North America led our global performance with a 6.3% year-over-year revenue increase. By leveraging our Microsoft cloud strategy and scalable SaaS platform, we are accelerating our clients' migration to the cloud."

    "Our continued investment in a future-proof, modular, open insurance platform-integrating core capabilities with advanced data analytics and AI-is set to drive further growth. We are well positioned to deepen relationships with existing customers, capture additional market share, and strengthen growth across all regions."

    "We are introducing 2025 guidance for non-GAAP revenue in a range of $553 million to $558 million, and non-GAAP operating profit in a range of $98 million to $102 million with operating margin of 18% at the midpoint. On a constant currency basis, our growth rate would be 3.4%, and our operating margin would be 18.7% at the mid-point."

    Quarterly Results Conference Call

    Management will host a conference call and webcast today, February 18, 2025, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens' results. Please call the following numbers (at least 10 minutes before the scheduled time) to participate:

    North America (toll-free): 1-888-642-5032

    International: 972-3-9180644

    UK: 0-800-917-5108

    The live webcast of the call can be viewed on Sapiens' website at: veidan.activetrail.biz/sapiensq4-2024. A replay of the call will be available one business day following the completion of the event at the same link for 90 days.

    Non-GAAP Financial Measures

    This press release contains the following non-GAAP financial measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income attributed to Sapiens shareholders, non-GAAP basic and diluted earnings per share, Adjusted EBITDA and Adjusted Free Cash-Flow.

    Sapiens believes that these non-GAAP measures of financial results provide useful information to management and investors regarding certain financial and business trends relating to Sapiens' financial condition and results of operations. The Company's management uses these non-GAAP measures to compare the Company's performance to that of prior periods for trend analyses, for purposes of determining executive and senior management incentive compensation and for budgeting and planning purposes. These measures are used in financial reports prepared for management and in quarterly financial reports presented to the Company's board of directors. The Company believes that the use of these non-GAAP financial measures provides an additional tool for investors to use in evaluating ongoing operating results and trends, and in comparing the Company's financial measures with other software companies, many of which present similar non-GAAP financial measures to investors.

    Non-GAAP financial measures consist of GAAP financial measures adjusted to exclude: Valuation adjustment on acquired deferred revenue, amortization of capitalized software development and other intangible assets, capitalization of software development, stock-based compensation, compensation related to acquisition and acquisition-related costs, restructuring and cost reduction costs, and tax adjustments related to non-GAAP adjustments.

    Management of the Company does not consider these non-GAAP measures in isolation, or as an alternative to financial measures determined in accordance with GAAP. The principal limitation of these non-GAAP financial measures is that they exclude significant expenses and income that are required by GAAP to be recorded in the Company's financial statements. In addition, they are subject to inherent limitations, as they reflect the exercise of judgment by management about which expenses and income are excluded or included in determining these non-GAAP financial measures.

    To compensate for these limitations, management presents non-GAAP financial measures in connection with GAAP results. Sapiens urges investors to review the reconciliation of its non-GAAP financial measures to the comparable GAAP financial measures, which it includes in press releases announcing quarterly financial results, including this press release, and not to rely on any single financial measure to evaluate the Company's business.

    Reconciliation tables of the most comparable GAAP financial measures to the non-GAAP financial measures used in this press release are included with the financial tables of this release.

    The Company defines Annual Recurring Revenue ("ARR") as the annualized value of our revenue from customer subscriptions, term licenses, maintenance, application maintenance, and cloud solutions, which may not be the same as the timing and amount of revenue recognized. The ARR run rate is equal to the product of (i) the sum of these revenues in our most recently completed fiscal quarter, multiplied by (ii) four.

    The Company defines Adjusted EBITDA as net profit, adjusted to eliminate valuation adjustment on acquired deferred revenue, stock-based compensation expense, depreciation and amortization, capitalization of software development costs, compensation expenses related to acquisition and acquisition-related costs, restructuring and cost reduction costs, financial expense (income), provision for income taxes and other income (expenses). These amounts are often excluded by other companies as well, in order to help investors understand the operational performance of their business.

    The Company uses Adjusted EBITDA as a measurement of its operating performance, because it assists in comparing the operating performance on a consistent basis by removing the impact of certain non-cash and non-operating items. Adjusted EBITDA reflects an additional way of viewing aspects of the operations that the Company believes, when viewed with the GAAP results and the accompanying reconciliations to corresponding GAAP financial measures, provide a more complete understanding of factors and trends affecting its business. The Company uses Adjusted Free Cash-Flow as a measurement of its operating performance, and reconciles cash-flow from operating activities to Adjusted Free Cash-Flow, while reducing the amounts for capitalization of software development costs and capital expenditures. The Company adds back cash payments made for former acquisitions in respect of future performance targets and retention criteria as determined upon acquisition date of the respective acquired company, which were included in the cash-flow from operating activities. We believe that Adjusted Free Cash-Flow is useful in evaluating our business, because Adjusted Free Cash-Flow reflects the cash surplus available to fund the expansion of our business.

    About Sapiens

    Sapiens International Corporation (NASDAQ and TASE: SPNS) is a global leader in intelligent insurance software solutions. With Sapiens' robust platform, customer-driven partnerships, and rich ecosystem, insurers are empowered to future-proof their organizations with operational excellence in a rapidly changing marketplace. We help insurers harness the power of AI and advanced automation to support core solutions for property and casualty, workers' compensation, and life insurance, including reinsurance, financial & compliance, data & analytics, digital, and decision management. Sapiens boasts a longtime global presence, serving over 600 customers in more than 30 countries with its innovative SaaS offerings. Recognized by industry experts and selected for the Microsoft Top 100 Partner program, Sapiens is committed to partnering with our customers for their entire transformation journey and is continuously innovating to ensure their success.

    Investor and Media Contact

    Yaffa Cohen-Ifrah

    Chief Marketing Officer and Head of Investor Relations, Sapiens

    [email protected]

    +1 917-533-4782

    Investor Contacts

    Brett Maas

    Managing Partner, Hayden IR

    +1 646-536-7331

    [email protected]

    Kimberly Rogers

    Managing Director, Hayden IR

    +1 541-904-5075

    [email protected]

     

    Forward Looking Statements

    Certain matters discussed in this press release that are incorporated herein by reference are forward-looking statements within the meaning of Section 27A of the Securities Act, Section 21E of the Exchange Act and the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, that are based on our beliefs, assumptions and expectations, as well as information currently available to us. Such forward-looking statements may be identified by the use of the words "anticipate," "believe," "estimate," "expect," "may," "will," "plan" and similar expressions. Such statements reflect our current views with respect to future events and are subject to certain risks and uncertainties. There are important factors that could cause our actual results, levels of activity, performance or achievements to differ materially from the results, levels of activity, performance or achievements expressed or implied by the forward-looking statements, including, but not limited to: the degree of our success in our plans to leverage our global footprint to grow our sales; the degree of our success in integrating the companies that we have acquired through the implementation of our M&A growth strategy; the lengthy development cycles for our solutions, which may frustrate our ability to realize revenues and/or profits from our potential new solutions; our lengthy and complex sales cycles, which do not always result in the realization of revenues; the degree of our success in retaining our existing customers or competing effectively for greater market share; difficulties in successfully planning and managing changes in the size of our operations; the frequency of the long-term, large, complex projects that we perform that involve complex estimates of project costs and profit margins, which sometimes change mid-stream; the challenges and potential liability that heightened privacy laws and regulations pose to our business; occasional disputes with clients, which may adversely impact our results of operations and our reputation; various intellectual property issues related to our business; potential unanticipated product vulnerabilities or cybersecurity breaches of our or our customers' systems; risks related to the insurance industry in which our clients operate; risks associated with our global sales and operations, such as changes in regulatory requirements, wide-spread viruses and epidemics like the recent novel coronavirus pandemic, which adversely affected our results of operations, or fluctuations in currency exchange rates; and risks related to our principal location in Israel and our status as a Cayman Islands company. While we believe such forward-looking statements are based on reasonable assumptions, should one or more of the underlying assumptions prove incorrect, or these risks or uncertainties materialize, our actual results may differ materially from those expressed or implied by the forward-looking statements. Please read the risks discussed under the heading "Risk Factors" in our most recent Annual Report on Form 20-F, in order to review conditions that we believe could cause actual results to differ materially from those contemplated by the forward-looking statements. You should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee that future results, levels of activity, performance and events and circumstances reflected in the forward-looking statements will be achieved or will occur. Except as required by law, we undertake no obligation to update publicly any forward-looking statements for any reason, to conform these statements to actual results or to changes in our expectations.

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

    CONDENSED CONSOLIDATED STATEMENT OF INCOME        

    U.S. dollars in thousands (except per share amounts)







      Three months ended



    Year ended







     December 31,



     December 31,







    2024



    2023



    2024



    2023







     (unaudited)



     (unaudited)



     (unaudited)



     (unaudited)





















     Revenue



    134,305



    130,859



    542,379



    514,584

     Cost of revenue



    74,158



    74,910



    304,272



    294,990





















     Gross profit



    60,147



    55,949



    238,107



    219,594





















     Operating expenses:



















     Research and development, net



    16,523



    16,084



    66,302



    63,475



     Selling, marketing, general and

     administrative



    21,926



    19,776



    85,956



    77,251

     Total operating expenses



    38,449



    35,860



    152,258



    140,726





















     Operating income



    21,698



    20,089



    85,849



    78,868





















     Financial and other expenses (income), net



    (864)



    (560)



    (3,978)



    1,750

     Taxes on income



    4,695



    3,624



    17,507



    14,251









































     Net income



    17,867



    17,025



    72,320



    62,867





















     Attributable to non-controlling interest



    -



    52



    141



    423





















     Net income attributable to Sapiens'

     shareholders



    17,867



    16,973



    72,179



    62,444









































     Basic earnings per share



    0.32



    0.30



    1.29



    1.13





















     Diluted earnings per share



    0.32



    0.30



    1.29



    1.12







































    Weighted average number of shares

    outstanding used to compute basic earnings

    per share (in thousands)



    55,887



    55,733



    55,821



    55,372

    Weighted average number of shares

    outstanding used to compute diluted earnings

    per share (in thousands)



    56,164



    55,910



    56,154



    55,721

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND SUBSIDIARIES 

    RECONCILIATION OF GAAP TO NON-GAAP RESULTS

    U.S. dollars in thousands (except per share amounts)





    Three months ended



    Year ended





    December 31,



    December 31,





    2024



    2023



    2024



    2023





    (unaudited)



    (unaudited)



    (unaudited)



    (unaudited)



















    GAAP revenue



    134,305



    130,859



    542,379



    514,584

    Valuation adjustment on acquired deferred

    revenue



    -



    55



    -



    220

    Non-GAAP revenue



    134,305



    130,914



    542,379



    514,804



















    GAAP gross profit



    60,147



    55,949



    238,107



    219,594

    Revenue adjustment



    -



    55



    -



    220

    Amortization of capitalized software



    1,540



    1,501



    6,124



    5,775

    Amortization of other intangible assets



    1,005



    1,865



    4,635



    7,396

    Non-GAAP gross profit



    62,692



    59,370



    248,866



    232,985



















    GAAP operating income



    21,698



    20,089



    85,849



    78,868

    Gross profit adjustments



    2,545



    3,421



    10,759



    13,391

    Capitalization of software development



    (1,759)



    (1,543)



    (7,133)



    (6,518)

    Amortization of other intangible assets



    1,211



    1,169



    4,943



    4,403

    Stock-based compensation



    723



    698



    2,952



    3,658

    Acquisition-related costs (*)



    50



    318



    1,298



    339

    Non-GAAP operating income



    24,468



    24,152



    98,668



    94,141



















    GAAP net income attributable to Sapiens' 

    shareholders



    17,867



    16,973



    72,179



    62,444

    Operating income adjustments



    2,770



    4,063



    12,819



    15,273

    Taxes on income



    73



    (955)



    (1,735)



    (2,693)

    Non-GAAP net income attributable to

    Sapiens' shareholders



    20,710



    20,081



    83,263



    75,024

     (*) Acquisition-related costs pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

     

    Adjusted EBITDA Calculation

    U.S. dollars in thousands





    Three months ended



    Year ended





     December 31,



     December 31,





    2024



    2023



    2024



    2023



















    GAAP operating profit



    21,698



    20,089



    85,849



    78,868



















    Non-GAAP adjustments:

















    Valuation adjustment on acquired deferred

    revenue



    -



    55



    -



    220

    Amortization of capitalized software



    1,540



    1,501



    6,124



    5,775

    Amortization of other intangible assets



    2,216



    3,034



    9,578



    11,799

    Capitalization of software development



    (1,759)



    (1,543)



    (7,133)



    (6,518)

    Stock-based compensation



    723



    698



    2,952



    3,658

    Compensation related to acquisition and

    acquisition-related costs



    50



    318



    1,298



    339



















    Non-GAAP operating profit



    24,468



    24,152



    98,668



    94,141



















    Depreciation



    891



    1,115



    4,371



    3,865



















    Adjusted EBITDA



    25,359



    25,267



    103,039



    98,006





































     

    Summary of NON-GAAP Financial Information 

    U.S. dollars in thousands (except per share amounts)



    Q4 2024



    Q3 2024



    Q2 2024



    Q1 2024



    Q4 2023





















    Revenues

    134,305



    137,025



    136,800



    134,249



    130,914

    Gross profit

    62,692



    62,809



    62,481



    60,884



    59,370

    Operating income

    24,468



    25,101



    24,836



    24,263



    24,152

    Adjusted EBITDA

    25,359



    26,389



    25,931



    25,360



    25,267

    Net income to Sapiens' shareholders

    20,710



    21,091



    21,041



    20,421



    20,081





















    Diluted earnings per share

    0.37



    0.37



    0.37



    0.36



    0.36

     

    Annual Recurring Revenue ("ARR")

    U.S. dollars in thousands 



    Three months ended



    December 31,



    2024



    2023

    Annual Recurring Revenue

    175,542



    164,840

     

    Non-GAAP Revenues by Geographic Breakdown

    U.S. dollars in thousands



    Q4 2024



    Q3 2024



    Q2 2024



    Q1 2024



    Q4 2023





















    North America

    56,753



    55,755



    57,918



    55,158



    54,882

    Europe

    65,903



    69,281



    66,072



    68,727



    65,239

    Rest of the World

    11,649



    11,989



    12,810



    10,364



    10,793





















    Total

    134,305



    137,025



    136,800



    134,249



    130,914

     

    Non-GAAP Revenue breakdown

    U.S. dollars in thousands



    Three months ended



    Year ended



    December 31,



    December 31,



    2024



    2023



    2024



    2023

















    Software products and re-occurring post-production services (*)

    97,336



    90,399



    390,328



    342,156

    Pre-production implementation services (**)

    36,969



    40,515



    152,051



    172,648

















    Total Revenues

    134,305



    130,914



    542,379



    514,804

















     



    Three months ended



    Year ended



    December 31,



    December 31,



    2024



    2023



    2024



    2023

















    Software products and re-occurring post-production services (*)

    52,356



    48,815



    208,742



    182,154

    Pre-production implementation services (**)

    10,336



    10,555



    40,124



    50,831

















    Total Gross profit

    62,692



    59,370



    248,866



    232,985

     



    Three months ended



    Year ended



    December 31,



    December 31,



    2024



    2023



    2024



    2023

















    Software products and re-occurring post-production services (*)

    53.8 %



    54.0 %



    53.5 %



    53.2 %

    Pre-production implementation services (**)

    28.0 %



    26.1 %



    26.4 %



    29.4 %

















    Gross Margin

    46.7 %



    45.4 %



    45.9 %



    45.3 %

    (*) Software products and re-occurring post-production services include mainly subscription, term license, maintenance, application maintenance, cloud solutions and post-production services. This revenue stream is a mix of recurring and re-occurring in nature. 

    (**) Pre-production implementation services include mainly implementation services before go-live, which are one-time in nature.

     

    Adjusted Free Cash-Flow

    U.S. dollars in thousands



    Q4 2024



    Q3 2024



    Q2 2024



    Q1 2024



    Q4 2023





















    Cash-flow from operating activities

    42,109



    13,083



    8,545



    18,488



    38,646

    Increase in capitalized software development costs

    (1,759)



    (1,834)



    (1,823)



    (1,717)



    (1,543)

    Capital expenditures

    (419)



    (1,125)



    (666)



    (466)



    (421)

    Free cash-flow

    39,931



    10,124



    6,056



    16,305



    36,682





















    Cash payments attributed to acquisition-related

    costs(*) (**)

    1,238



    124



    134



    751



    221





















    Adjusted free cash-flow

    41,169



    10,248



    6,190



    17,056



    36,903

     

    (*) Included in cash-flow from operating activities

    (**) Acquisition-related payments pertain to charges on behalf of M&A agreements related to future performance targets and retention criteria, as well as completed or prospective third-party services, such as tax, accounting and legal rendered.

     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

    CONDENSED CONSOLIDATED BALANCE SHEET

    U.S. dollars in thousands







    December 31,



    December 31,







    2024



    2023







     (unaudited)



     (unaudited)













     ASSETS























     CURRENT ASSETS











    Cash and cash equivalents



    163,690



    126,716



    Short-term bank deposit



    52,500



    75,400



    Trade receivables, net and unbilled receivables



    99,603



    90,273



    Other receivables and prepaid expenses



    19,350



    22,514



    Total current assets



    335,143



    314,903













     LONG-TERM ASSETS











    Property and equipment, net



    10,656



    12,661



    Severance pay fund



    3,208



    3,605



    Goodwill and intangible assets, net



    302,472



    317,352



    Operating lease right-of-use assets



    20,746



    23,557



    Other long-term assets



    19,486



    17,546



    Total long-term assets



    356,568



    374,721













     TOTAL ASSETS



    691,711



    689,624













    LIABILITIES AND EQUITY





















     CURRENT LIABILITIES











    Trade payables



    8,414



    6,291



    Current maturities of Series B Debentures



    19,796



    19,796



    Accrued expenses and other liabilities



    77,390



    77,873



    Current maturities of operating lease liabilities



    6,440



    6,623



    Deferred revenue



    37,543



    38,541



    Total current liabilities



    149,583



    149,124













     LONG-TERM LIABILITIES











    Series B Debentures, net of current maturities



    19,792



    39,543



    Deferred tax liabilities



    6,899



    10,820



    Other long-term liabilities



    10,331



    11,538



    Long-term operating lease liabilities



    17,719



    21,084



    Accrued severance pay



    7,758



    7,568



    Total long-term liabilities



    62,499



    90,553













    EQUITY





    479,629



    449,947













    TOTAL LIABILITIES AND EQUITY



    691,711



    689,624











     

    SAPIENS INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES

    CONSOLIDATED STATEMENT OF CASH FLOW

    U.S. dollars in thousands



    For the twelve months ended

    December 31,



    2024



    2023



    (unaudited)



    (unaudited)

    Cash flows from operating activities:







    Net income

    72,320



    62,867

    Reconciliation of net income to net cash provided by operating activities:







    Depreciation

    4,371



    3,865

    Amortization of capitalized software and other intangible assets

    15,702



    17,574

    Accretion of discount on Series B Debentures

    44



    64

    Capital loss from sale of property and equipment

    19



    195

    Stock-based compensation related to options issued to employees

    2,952



    3,658









    Net changes in operating assets and liabilities, net of amount acquired:







    Decrease (increase) in trade receivables, net and unbilled receivables

    (12,500)



    3,960

    Decrease in deferred tax liabilities, net

    (5,934)



    (3,003)

    Decrease (increase) in other operating assets

    5,343



    (5,402)

    Increase (decrease) in trade payables

    2,126



    (3,580)

    Decrease in other operating liabilities

    (2,558)



    (8,948)

    Increase (decrease) in deferred revenues

    (407)



    7,266

    Increase in accrued severance pay, net

    747



    909

    Net cash provided by operating activities

    82,225



    79,425









    Cash flows from investing activities:















    Purchase of property and equipment

    (2,879)



    (2,574)

    Proceeds from (investments in) deposits

    23,592



    (55,499)

    Proceeds from sale of property and equipment

    203



    48

    Payments for business acquisitions, net of cash acquired

    (375)



    (8,060)

    Capitalized software development costs

    (7,133)



    (6,518)

    Acquisition of intellectual property

    -



    (177)

    Net cash provided by (used in) investing activities

    13,408



    (72,780)









    Cash flows from financing activities:







    Proceeds from employee stock options exercised

    98



    4,809

    Distribution of dividend

    (31,823)



    (28,144)

    Repayment of Series B Debenture

    (19,796)



    (19,796)

    Acquisition deferred payment

    (630)



    -

    Acquisition of non-controlling interests

    (4,131)



    (161)

    Dividend to non-controlling interest

    -



    (47)

    Net cash used in financing activities

    (56,282)



    (43,339)









    Effect of exchange rate changes on cash and cash equivalents

    (2,377)



    3,125









    Increase (decrease) in cash and cash equivalents

    36,974



    (33,569)

    Cash and cash equivalents at the beginning of period

    126,716



    160,285









    Cash and cash equivalents at the end of period

    163,690



    126,716

     

    Debentures Covenants

    As of December 31, 2024, Sapiens was in compliance with all of its financial covenants under the indenture for the Series B Debentures, based on having achieved the following in its consolidated financial results:

    Covenant 1 

    • Target shareholders' equity (excluding non-controlling interest): above $120 million.
    • Actual shareholders' equity (excluding non-controlling interest) equal to $479.6 million.

    Covenant 2

    • Target ratio of net financial indebtedness to net capitalization (in each case, as defined under the indenture for the Company's Series B Debentures) below 65%.
    • Actual ratio of net financial indebtedness to net capitalization equal to (57.93)%.

    Covenant 3

    • Target ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is below 5.5.
    • Actual ratio of net financial indebtedness to EBITDA (accumulated calculation for the four last quarters) is equal to (1.71).

    Logo: https://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg

     

     

    Cision View original content:https://www.prnewswire.com/news-releases/sapiens-reports-fourth-quarter-2024-financial-results-302378798.html

    SOURCE Sapiens International Corporation

    Get the next $SPNS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SPNS

    DatePrice TargetRatingAnalyst
    2/3/2025$36.00 → $28.00Buy → Hold
    Jefferies
    5/5/2023$24.00Equal Weight → Underweight
    Barclays
    1/23/2023$28.00Buy
    Goldman
    12/1/2022$20.00Underweight
    JP Morgan
    2/24/2022$38.00 → $30.00Buy
    Citigroup
    2/24/2022$40.00 → $36.00Buy
    Needham
    12/14/2021Neutral → Underweight
    JP Morgan
    12/14/2021$35.00Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SPNS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Leading U.S. Auto Claims Organization Selects Sapiens to Modernize Operations

      Sapiens ClaimsPro to streamline operations, enhance reporting, and reduce technical debt for nonprofit auto claims servicing organization ROCHELLE PARK, N.J., May 21, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that a leading state-run auto insurance placement and claims organization has selected Sapiens ClaimsPro for Property & Casualty (P&C) to support its modernization efforts. The client, which specializes in administering auto claims services, selected Sapiens to replace a decade-old legacy system. The decision was driven by the need to streamline manual p

      5/21/25 6:38:00 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • Sapiens Hosts Global Client Conference in Vienna, Empowering Insurers to Lead Market Change

      Event brings insurance leaders together to share strategies for growth, agility, and business impact ROCHELLE PARK, N.J., May 15, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that its annual International Client Conference was held this week from May 12–14, 2025, in Vienna, Austria. The event brought together insurance customers, prospects, and partners from around the world for three days dedicated to business strategy, technology innovation, and peer-to-peer collaboration. This year's conference, themed Compose Your Future, reflected Sapiens' ongoing commitmen

      5/15/25 6:17:00 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • Global Insurance Leader Selected Sapiens to Innovate Operations

      First London Market Insurer to Leverage Sapiens' Innovative SaaS Solution with LORS & USM Messaging ROCHELLE PARK, N.J., May 13, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced that a European based global insurer has selected Sapiens ReinsuranceMaster and Sapiens DataSuite end-to-end SaaS solution to modernise its operations in the highly specialised London Market.  This marks a significant milestone for the insurer as it becomes the first London Market insurer to utilise Sapiens' innovative Lloyd's Outward Reinsurance Scheme (LORS) and Underwriting Support Message

      5/13/25 6:20:00 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology

    $SPNS
    Financials

    Live finance-specific insights

    See more
    • Sapiens Reports First Quarter 2025 Financial Results

      ROCHELLE PARK, N.J., May 8, 2025 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced its financial results for the first quarter ended March 31, 2025.     Summary Results for First Quarter 2025 (USD in millions, except per share data) GAAP Non-GAAP Q1 2025 Q1 2024 % Change Q1 2025 Q1 2024 % Change Revenue $136.1 $134.2 1.4 % $136.1 $134.2 1.4 % Gross Profit $60.7 $57.6 5.4 % $63.0 $60.9 3.5 % Gross Margin 44.6 % 42.9 %  170 bps 46.3 % 45.4 %  90 bps Operating Income $21.2 $20.5 3.3 % $24.6 $24.3 1.2 % Operating Margin 15.6 % 15.3 %  30 bps 18.0 % 18.1 %  -10 bps Net Income

      5/8/25 6:08:00 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • Sapiens Acquires AdvantageGo to Expand Global P&C Platform with Cutting-Edge Underwriting Workbench & Risk Management Capabilities

      Acquisition Strengthens Sapiens' Value Proposition Across Global Commercial, Specialty, and London Market Segments ROCHELLE PARK, N.J., April 28, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, announced today that it has signed a definitive agreement for the acquisition of AdvantageGo, a leading commercial insurance software provider specializing in underwriting workbench solutions for both London and global commercial markets. This strategic acquisition significantly enhances Sapiens' global P&C proposition, adding cutting-edge underwriting workbench capabilities that address one

      4/28/25 1:26:00 PM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • Sapiens Acquires Candela to Expand its Footprint in APAC and Enhance its Life Product Portfolio

      A Strategic Move to Strengthen Sapiens' Position in the APAC Market and Strengthen our Life Position Globally ROCHELLE PARK, N.J., April 22, 2025 /PRNewswire/ -- Sapiens International Corporation (NASDAQ:SPNS) (TASE: SPNS), a global leader in intelligent insurance software solutions today announced the acquisition of Candela, a leading intelligent automation company servicing blue-chip, APAC-based insurance clients. This strategic move aims to enhance Sapiens' life product portfolio and expand its presence in the APAC region. The transaction is subject to customary closing conditions and expected to close during the second quarter of 2025. Candela offers an end-to-end insurance automation p

      4/22/25 2:23:00 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology

    $SPNS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

      SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

      1/17/23 6:12:29 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

      SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

      7/28/22 6:03:57 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form SC 13G/A filed by Sapiens International Corporation N.V. (Amendment)

      SC 13G/A - SAPIENS INTERNATIONAL CORP N V (0000885740) (Subject)

      2/7/22 6:08:41 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology

    $SPNS
    SEC Filings

    See more
    • SEC Form 6-K filed by Sapiens International Corporation N.V.

      6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

      5/21/25 6:24:19 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 6-K filed by Sapiens International Corporation N.V.

      6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

      5/15/25 6:09:19 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • SEC Form 6-K filed by Sapiens International Corporation N.V.

      6-K - SAPIENS INTERNATIONAL CORP N V (0000885740) (Filer)

      5/13/25 6:13:37 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology

    $SPNS
    Leadership Updates

    Live Leadership Updates

    See more
    • Sapiens Appoints Jamie Yoder as North America President and General Manager

      HOLON, Israel, April 26, 2021 /PRNewswire/ -- Sapiens International Corporation, (NASDAQ:SPNS) (TASE: SPNS), a leading global provider of software solutions for the insurance industry, today announced the appointment of Jamie Yoder as President and General Manager of Sapiens North America. Mr. Yoder's depth of leadership experience in the insurance and technology sectors, including senior management positions at top global professional services firms (such as PwC), will further strengthen Sapiens' footprint, strategy, and operations in North America and globally. Sapiens will benefit from his strong acumen across various touchpoints within the insurance life cycle, especially in these times

      4/26/21 9:58:00 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology

    $SPNS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Sapiens Int'l downgraded by Jefferies with a new price target

      Jefferies downgraded Sapiens Int'l from Buy to Hold and set a new price target of $28.00 from $36.00 previously

      2/3/25 7:11:09 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • Sapiens Int'l downgraded by Barclays with a new price target

      Barclays downgraded Sapiens Int'l from Equal Weight to Underweight and set a new price target of $24.00

      5/5/23 7:20:13 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology
    • Goldman initiated coverage on Sapiens Int'l with a new price target

      Goldman initiated coverage of Sapiens Int'l with a rating of Buy and set a new price target of $28.00

      1/23/23 7:48:42 AM ET
      $SPNS
      Computer Software: Prepackaged Software
      Technology